The Prague Post - US House revolt advances Obamacare subsidy extension

EUR -
AED 4.245913
AFN 76.887634
ALL 93.218842
AMD 422.094755
AOA 1060.176801
ARS 1724.882567
AUD 1.638747
AWG 2.082489
AZN 1.97002
BAM 1.955776
BBD 2.321671
BDT 142.688227
BHD 0.434695
BIF 3451.157116
BMD 1.156136
BND 1.477082
BOB 13.69983
BRL 5.876989
BSD 1.152686
BTN 109.688637
BWP 15.558807
BYN 3.432357
BYR 22660.258427
BZD 2.318271
CAD 1.61333
CDF 2615.761404
CHF 0.93588
CLF 0.026829
CLP 1055.916879
CNY 7.801146
CNH 7.796152
COP 3633.55485
CRC 523.993489
CUC 1.156136
CUP 30.637594
CVE 110.26363
CZK 24.258158
DJF 205.267449
DKK 7.477932
DOP 67.289164
DZD 152.967099
EGP 57.380687
ERN 17.342035
ETB 186.049588
FJD 2.553384
FKP 0.857252
GBP 0.858527
GEL 3.017966
GGP 0.857252
GHS 13.526832
GIP 0.857252
GMD 84.980421
GNF 10123.874202
GTQ 8.794891
GYD 241.157003
HKD 9.067746
HNL 30.895616
HRK 7.536622
HTG 150.718127
HUF 363.096405
IDR 20580.370421
ILS 3.468234
IMP 0.857252
INR 110.076256
IQD 1509.981237
IRR 1590322.371805
ISK 142.598215
JEP 0.857252
JMD 183.057725
JOD 0.819746
JPY 182.445186
KES 149.158147
KGS 101.104505
KHR 4681.941823
KMF 492.514185
KRW 1627.677557
KWD 0.356853
KYD 0.960588
KZT 540.233287
LAK 26025.676609
LBP 103223.017367
LKR 386.635196
LRD 208.057415
LSL 18.726567
LTL 3.413768
LVL 0.699335
LYD 7.331909
MAD 10.743067
MDL 20.044751
MGA 4918.938878
MKD 61.524236
MMK 2427.363841
MNT 4157.293457
MOP 9.314584
MRU 46.338424
MUR 54.419742
MVR 17.862733
MWK 1998.775164
MXN 19.812061
MYR 4.728715
MZN 73.882892
NAD 18.726567
NGN 1577.963717
NIO 42.419473
NOK 10.99759
NPR 175.501819
NZD 1.966719
OMR 0.442445
PAB 1.152686
PEN 3.903651
PGK 5.093937
PHP 70.183258
PKR 320.014324
PLN 4.299905
PYG 6853.914834
QAR 4.213648
RON 5.244583
RSD 117.338542
RUB 94.338828
RWF 1694.978938
SAR 4.341973
SBD 9.325039
SCR 16.705092
SDG 694.263698
SEK 10.961095
SGD 1.477585
SLE 28.445176
SOS 658.791814
SRD 43.778814
STD 23929.673396
STN 24.499696
SVC 10.085875
SZL 18.722767
THB 38.210709
TJS 10.633568
TMT 4.058036
TND 3.386358
TRY 55.144784
TTD 7.812903
TWD 37.286072
TZS 3051.762079
UAH 51.625959
UGX 4293.946644
USD 1.156136
UYU 46.399423
UZS 13785.828699
VES 873.763846
VND 30295.956222
VUV 137.068136
WST 3.160546
XAF 655.948849
XAG 0.018188
XAU 0.000266
XCD 3.124515
XCG 2.077474
XDR 0.81579
XOF 655.948849
XPF 119.331742
YER 275.626884
ZAR 18.667336
ZMK 10406.612213
ZMW 21.75673
ZWL 372.275202
  • CMSC

    0.0240

    21.744

    +0.11%

  • RIO

    1.4500

    101.1

    +1.43%

  • VOD

    0.1900

    16.19

    +1.17%

  • BCC

    2.3400

    86.6

    +2.7%

  • RBGPF

    0.7600

    70.5

    +1.08%

  • RYCEF

    0.2300

    20.85

    +1.1%

  • RELX

    0.0485

    35.52

    +0.14%

  • NGG

    0.4700

    80.88

    +0.58%

  • CMSD

    -0.1600

    21.82

    -0.73%

  • BCE

    -0.0200

    22.75

    -0.09%

  • GSK

    0.7900

    52.96

    +1.49%

  • JRI

    0.1500

    12.81

    +1.17%

  • BTI

    0.6000

    59.33

    +1.01%

  • BP

    -0.6000

    41.63

    -1.44%

  • AZN

    1.4100

    161.42

    +0.87%

US House revolt advances Obamacare subsidy extension
US House revolt advances Obamacare subsidy extension / Photo: Alex Edelman - AFP

US House revolt advances Obamacare subsidy extension

US lawmakers voted Thursday to revive health insurance subsidies that expired at the end of last year, offering hope to millions of Americans facing steep premium hikes -- and pressuring the Senate to follow suit.

Text size:

The bill, which passed with Democratic support and backing from a small bloc of Republicans defying their own leadership, would extend enhanced subsidies under the Affordable Care Act -- widely known as Obamacare -- for three years.

Those subsidies lower monthly insurance costs for Americans who buy coverage on government-run marketplaces.

Their expiration on January 1 more than doubled payments for many households, reigniting a politically sensitive debate over health care affordability in a year set to be dominated by the high-stakes midterm congressional elections.

Even supporters concede the House bill is unlikely to become law in its current form.

President Donald Trump has criticized the subsidies as wasteful and has urged Republicans to push for changes, though he has also told lawmakers they may need to be flexible to reach a deal.

House Speaker Mike Johnson, a staunch Trump loyalist, had resisted allowing the measure onto the floor, reflecting deep divisions within his party over the program.

But a handful of centrist Republicans joined Democrats in using a rarely successful procedural maneuver -- a discharge petition -- to force the vote over leadership's objections.

Ultimately, 17 Republicans voted with Democrats to pass the bill, a public break that underscored growing anxiety among lawmakers from competitive districts about voter backlash over rising healthcare costs.

"The affordability crisis is not a hoax. It is very real despite what Donald Trump has had to say," Hakeem Jeffries, the leader of the House Democratic minority, told reporters.

"Housing costs are too high. Grocery costs are too high. Utility bills are too high. Childcare costs are too high. And healthcare costs are out of control."

The subsidies were originally created under the Affordable Care Act and expanded during the Covid-19 pandemic, making coverage cheaper and available to more people. An estimated 22 million Americans currently benefit from the enhanced assistance.

The bill now heads to the Senate, where its fate is uncertain. A similar three-year extension failed there in December, falling short of the 60-vote threshold needed to advance.

The nonpartisan Congressional Budget Office estimates a three-year clean extension of enhanced Obamacare subsidies would cost almost $81 billion over a decade -- but would lead to eight million more people getting health insurance by 2029.

The House vote appears to have injected new momentum into bipartisan talks now underway in the upper chamber.

A small group of senators from both parties has been negotiating a narrower compromise that could include a shorter extension, tighter income limits and new options for directing aid straight to patients rather than insurers.

Z.Pavlik--TPP